ABSTRACT
BACKGROUND: The impact of various clinical variables on long-term survival of patients with acutely decompensated diastolic heart failure (DHF) compared to systolic heart failure (SHF) has not been sufficiently investigated. METHODS: Clinical, laboratory, electrocardiographic and echocardiographic data were collected and analyzed for all-cause mortality in 473 furosemide-treated patients aged >or=60 years, hospitalized for acutely decompensated HF. RESULTS: Diastolic heart failure patients (n = 183) were more likely to be older, female, hypertensive, obese, with shorter preexisting HF duration, atrial fibrillation, lower New York Heart Association (NYHA) class, lower maintenance furosemide dosages, and to receive calcium antagonists. The SHF group (290 patients) demonstrated prevailing coronary artery disease, nitrate or digoxin treatment, and electrocardiographic conduction disturbances (P Subject(s)
Diuretics/administration & dosage
, Furosemide/administration & dosage
, Heart Failure, Diastolic/mortality
, Heart Failure, Systolic/mortality
, Aged
, Aged, 80 and over
, Echocardiography
, Electrocardiography
, Female
, Follow-Up Studies
, Heart Failure, Diastolic/drug therapy
, Heart Failure, Diastolic/physiopathology
, Heart Failure, Systolic/drug therapy
, Heart Failure, Systolic/physiopathology
, Humans
, Hypertension/complications
, Hypolipidemic Agents/therapeutic use
, Male
, Middle Aged
, Obesity/complications
, Prognosis
, Risk Factors
, Sex Factors
, Survival Rate
, Time Factors
